Effects of risk factors for and components of metabolic syndrome on the quality of life of patients with systemic lupus erythematosus: a structural equation modeling approach

Quality of Life Research

Volumn 27, Issue 1, 2018, Pages 105-113

  Lee, Jeong Won ^a   Kang, Ji Hyoun ^a   Lee, Kyung Eun ^a   Park, Dong Jin ^a   Kang, Seong Wook ^b   Kwok, Seung Ki ^c   Kim, Seong Kyu ^d   Choe, Jung Yoon ^d   Kim, Hyoun Ah ^e   Sung, Yoon Kyoung ^f   Shin, Kichul ^g   Lee, Sang Il ^h   Lee, Chang Hoon ⁱ   Choi, Sung Jae ^j   Lee, Shin Seok ^a  

^a Chonnam National University Medical School   (South Korea)

^b Chungnam National University   (South Korea)

^c The Catholic University of Korea   (South Korea)

^d Catholic University of Daegu   (South Korea)

^e Ajou University Medical Center   (South Korea)

^f Hanyang University Hospital for Rheumatic Diseases   (South Korea)

^g Seoul National University Boramae Hospital   (South Korea)

^h Gyeongsang National University School of Medicine   (South Korea)

ⁱ Wonkwang University   (South Korea)

^j Korea University College of Medicine   (South Korea)

more..

Author keywords

Depression; Metabolic syndrome; Quality of life; Systemic lupus erythematosus

Indexed keywords

CORTICOSTEROID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL ASSESSMENT; COHORT ANALYSIS; DEPRESSION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; EDUCATIONAL STATUS; FEMALE; GLOBAL ASSESSMENT OF FUNCTIONING; HOUSEHOLD INCOME; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTICENTER STUDY; PATIENT RISK; PHYSICIANS GLOBAL ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTOR; SHORT FORM 36; SLEDAI; SOCIAL STATUS; STRUCTURAL EQUATION MODELING; SYSTEMIC LUPUS ERYTHEMATOSUS; TIME TO TREATMENT; COMPLICATION; METHODOLOGY; PATHOLOGY; PSYCHOLOGY;

ADULT; COHORT STUDIES; DEPRESSION; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; METABOLIC SYNDROME; PROSPECTIVE STUDIES; QUALITY OF LIFE; RESEARCH DESIGN; RISK FACTORS;

EID: 85027835352     PISSN: 09629343     EISSN: 15732649     Source Type: Journal    
DOI: 10.1007/s11136-017-1689-z     Document Type: Article

References (44)

1. American Heart, A., National Heart, L., Blood, I., Grundy, S. M., Cleeman, J. I., Daniels, S. R., et al. (2005). Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. Cardiol Rev, 13(6), 322–327.
2. Lim, S., Shin, H., Song, J. H., Kwak, S. H., Kang, S. M., Won Yoon, J., et al. (2011). Increasing prevalence of metabolic syndrome in Korea: the Korean National Health and Nutrition Examination Survey for 1998-2007. Diabetes Care, 34(6), 1323–1328.
3. Ford, E. S. (2005). Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care, 28(7), 1769–1778.
4. Parker, B., Urowitz, M. B., Gladman, D. D., Lunt, M., Donn, R., Bae, S. C., et al. (2015). Impact of early disease factors on metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort. Annals of the Rheumatic Diseases, 74(8), 1530–1536.
5. Lozovoy, M. A., Simao, A. N., Hohmann, M. S., Simao, T. N., Barbosa, D. S., Morimoto, H. K., et al. (2011). Inflammatory biomarkers and oxidative stress measurements in patients with systemic lupus erythematosus with or without metabolic syndrome. Lupus, 20(13), 1356–1364.
6. Ugarte-Gil, M. F., Sanchez-Zuniga, C., Gamboa-Cardenas, R. V., Aliaga-Zamudio, M., Zevallos, F., Tineo-Pozo, G., et al. (2015). Circulating naive and memory CD4 + T cells and metabolic syndrome in patients with systemic lupus erythematosus: data from a primarily Mestizo population. Rheumatology (Oxford), 54(7), 1302–1307.
7. Bultink, I. E., Turkstra, F., Diamant, M., Dijkmans, B. A., & Voskuyl, A. E. (2008). Prevalence of and risk factors for the metabolic syndrome in women with systemic lupus erythematosus. Clinical and Experimental Rheumatology, 26(1), 32–38.
8. Sabio, J. M., Zamora-Pasadas, M., Jimenez-Jaimez, J., Albadalejo, F., Vargas-Hitos, J., Rodriguez del Aguila, M. D., et al. (2008). Metabolic syndrome in patients with systemic lupus erythematosus from Southern Spain. Lupus, 17(9), 849–859.
9. Bellomio, V., Spindler, A., Lucero, E., Berman, A., Sueldo, R., Berman, H., et al. (2009). Metabolic syndrome in Argentinean patients with systemic lupus erythematosus. Lupus, 18(11), 1019–1025.
10. Medeiros, M. M., Xavier de Oliveira, I. M., & Ribeiro, A. T. (2016). Prevalence of metabolic syndrome in a cohort of systemic lupus erythematosus patients from Northeastern Brazil: association with disease activity, nephritis, smoking, and age. Rheumatology International, 36(1), 117–124.
11. Muniz, L. F., Pereira, R. M., Silva, T. F., Bonfa, E., & Borba, E. F. (2015). Impact of Therapy on Metabolic Syndrome in Young Adult Premenopausal Female Lupus Patients: Beneficial Effect of Antimalarials. Arthritis Care Res (Hoboken), 67(9), 1255–1262.
12. Parker, B., Urowitz, M. B., Gladman, D. D., Lunt, M., Bae, S. C., Sanchez-Guerrero, J., et al. (2013). Clinical associations of the metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort. Annals of the Rheumatic Diseases, 72(8), 1308–1314.
13. Parker, B., Ahmad, Y., Shelmerdine, J., Edlin, H., Yates, A. P., Teh, L. S., et al. (2011). An analysis of the metabolic syndrome phenotype in systemic lupus erythematosus. Lupus, 20(14), 1459–1465.
14. Demir, S., Artim-Esen, B., Sahinkaya, Y., Pehlivan, O., Alpay-Kanitez, N., Omma, A., et al. (2016). Metabolic syndrome is not only a risk factor for cardiovascular diseases in systemic lupus erythematosus but is also associated with cumulative organ damage: a cross-sectional analysis of 311 patients. Lupus, 25(2), 177–184.
15. Negron, A. M., Molina, M. J., Mayor, A. M., Rodriguez, V. E., & Vila, L. M. (2008). Factors associated with metabolic syndrome in patients with systemic lupus erythematosus from Puerto Rico. Lupus, 17(4), 348–354.
16. Gheita, T. A., Raafat, H. A., Sayed, S., El-Fishawy, H., Nasrallah, M. M., & Abdel-Rasheed, E. (2013). Metabolic syndrome and insulin resistance comorbidity in systemic lupus erythematosus. Effect on carotid intima-media thickness. Zeitschrift fur Rheumatologie, 72(2), 172–177.
17. Hochberg, M. C. (1997). Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis and Rheumatism, 40(9), 1725.
18. Lee, S. Y., Park, H. S., Kim, D. J., Han, J. H., Kim, S. M., Cho, G. J., et al. (2007). Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Research and Clinical Practice, 75(1), 72–80.
19. Petri, M., Kim, M. Y., Kalunian, K. C., Grossman, J., Hahn, B. H., Sammaritano, L. R., et al. (2005). Combined oral contraceptives in women with systemic lupus erythematosus. New England Journal of Medicine, 353(24), 2550–2558.
20. Rhee, M. K., Lee, Y. H., Park, S. H., Sohn, C. H., Chung, Y. C., Hong, S. K., et al. (1995). A standardization study of Beck Depression Inventory I - Korean version (K-BDI): Reliability and factor analysis. Kor J Psychopathol, 4(1), 77–95.
21. Han, C. W., Lee, E. J., Iwaya, T., Kataoka, H., & Kohzuki, M. (2004). Development of the Korean version of Short-Form 36-Item Health Survey: health related QOL of healthy elderly people and elderly patients in Korea. Tohoku Journal of Experimental Medicine, 203(3), 189–194.
22. Anderson, J. C., & Gerbing, D. W. (1988). Structural equation modeling in practice: A review and recommended two step approach. Psychological Bulletin, 103(3), 411–423.
23. Chung, C. P., Avalos, I., Oeser, A., Gebretsadik, T., Shintani, A., Raggi, P., et al. (2007). High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors. Annals of the Rheumatic Diseases, 66(2), 208–214.
24. Liu, S. Y., Han, L. S., Guo, J. Y., Zheng, Z. H., Li, H., Zhang, L., et al. (2013). Metabolic syndrome in Chinese patients with systemic lupus erythematosus: no association with plasma cortisol level. Lupus, 22(5), 519–526.
25. Dallongeville, J., Cottel, D., Ferrieres, J., Arveiler, D., Bingham, A., Ruidavets, J. B., et al. (2005). Household income is associated with the risk of metabolic syndrome in a sex-specific manner. Diabetes Care, 28(2), 409–415.
26. Lidfeldt, J., Nyberg, P., Nerbrand, C., Samsioe, G., Schersten, B., & Agardh, C. D. (2003). Socio-demographic and psychosocial factors are associated with features of the metabolic syndrome. The Women’s Health in the Lund Area (WHILA) study. Diabetes, Obesity & Metabolism, 5(2), 106–112.
27. Diez Roux, A. V., Jacobs, D. R., Kiefe, C. I., & Coronary Artery Risk Developoment in Young Adults, S. (2002). Neighborhood characteristics and components of the insulin resistance syndrome in young adults: the coronary artery risk development in young adults (CARDIA) study. Diabetes Care, 25(11), 1976–1982.
28. Albert, M. A., Glynn, R. J., Buring, J., & Ridker, P. M. (2006). Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events. Circulation, 114(24), 2619–2626.
29. Kim, S. R., Han, K., Choi, J. Y., Ersek, J., Liu, J., Jo, S. J., et al. (2015). Age- and sex-specific relationships between household income, education, and diabetes mellitus in Korean adults: the Korea National Health and Nutrition Examination Survey, 2008-2010. PLoS ONE, 10(1), e0117034.
30. Drewnowski, A., & Specter, S. E. (2004). Poverty and obesity: the role of energy density and energy costs. American Journal of Clinical Nutrition, 79(1), 6–16.
31. Booth, S. L., Sallis, J. F., Ritenbaugh, C., Hill, J. O., Birch, L. L., Frank, L. D., et al. (2001). Environmental and societal factors affect food choice and physical activity: rationale, influences, and leverage points. Nutr Rev, 59(3 Pt 2), S21-39; discussion S57-65.
32. Wardle, J., Waller, J., & Jarvis, M. J. (2002). Sex differences in the association of socioeconomic status with obesity. American Journal of Public Health, 92(8), 1299–1304.
33. Miettola, J., Niskanen, L. K., Viinamaki, H., Sintonen, H., & Kumpusalo, E. (2008). Metabolic syndrome is associated with impaired health-related quality of life: Lapinlahti 2005 study. Quality of Life Research, 17(8), 1055–1062.
34. Tziallas, D., Kastanioti, C., Kostapanos, M. S., Skapinakis, P., Elisaf, M. S., & Mavreas, V. (2012). The impact of the metabolic syndrome on health-related quality of life: a cross-sectional study in Greece. Eur J Cardiovasc Nurs, 11(3), 297–303.
35. Ford, E. S., & Li, C. (2008). Metabolic syndrome and health-related quality of life among U.S. adults. Annals of Epidemiology, 18(3), 165–171.
36. Sohn, Y. J., Sohn, H. S., & Kwon, J. W. (2011). Gender differences among middle-aged Koreans for health-related quality of life related to metabolic syndrome. Quality of Life Research, 20(4), 583–592.
37. Park, S. S., Yoon, Y. S., & Oh, S. W. (2011). Health-related quality of life in metabolic syndrome: The Korea National Health and Nutrition Examination Survey 2005. Diabetes Research and Clinical Practice, 91(3), 381–388.
38. Lee, Y. J., Woo, S. Y., Ahn, J. H., Cho, S., & Kim, S. R. (2012). Health-related quality of life in adults with metabolic syndrome: the Korea national health and nutrition examination survey, 2007-2008. Annals of Nutrition & Metabolism, 61(4), 275–280.
39. Han, J. H., Park, H. S., Shin, C. I., Chang, H. M., Yun, K. E., Cho, S. H., et al. (2009). Metabolic syndrome and quality of life (QOL) using generalised and obesity-specific QOL scales. International Journal of Clinical Practice, 63(5), 735–741.
40. Carpenter, K. M., Hasin, D. S., Allison, D. B., & Faith, M. S. (2000). Relationships between obesity and DSM-IV major depressive disorder, suicide ideation, and suicide attempts: results from a general population study. American Journal of Public Health, 90(2), 251–257.
41. Das, U. N. (2002). Is metabolic syndrome X an inflammatory condition? Exp Biol Med (Maywood), 227(11), 989–997.
42. Strouse, T. B. (2007). The relationship between cytokines and pain/depression: a review and current status. Current Pain and Headache Reports, 11(2), 98–103.
43. Akbaraly, T. N., Kivimaki, M., Brunner, E. J., Chandola, T., Marmot, M. G., Singh-Manoux, A., et al. (2009). Association between metabolic syndrome and depressive symptoms in middle-aged adults: results from the Whitehall II study. Diabetes Care, 32(3), 499–504.
44. Vetter, M. L., Wadden, T. A., Lavenberg, J., Moore, R. H., Volger, S., Perez, J. L., et al. (2011). Relation of health-related quality of life to metabolic syndrome, obesity, depression and comorbid illnesses. Int J Obes (Lond), 35(8), 1087–1094.